29 Jul 2020 - The Intercept

UNITED STATES - AUGUST 9: JD Scholten, Democratic candidate for Iowa's 4th congressional district, speaks at the Iowa Democratic Wing Ding at the Surf Ballroom on Friday August 9, 2019. (Photo by Caroline Brehman/CQ Roll Call)

Progressive J.D. Scholten Rejects DCCC Help in Close Iowa Race

UNITED STATES - AUGUST 9: JD Scholten, Democratic candidate for Iowa's 4th congressional district, speaks at the Iowa Democratic Wing Ding at the Surf Ballroom on Friday August 9, 2019. (Photo by Caroline Brehman/CQ Roll Call)

Progressive J.D. Scholten Rejects DCCC Help in Close Iowa Race

UNITED STATES - AUGUST 9: JD Scholten, Democratic candidate for Iowa's 4th congressional district, speaks at the Iowa Democratic Wing Ding at the Surf Ballroom on Friday August 9, 2019. (Photo by Caroline Brehman/CQ Roll Call)

Progressive J.D. Scholten Rejects DCCC Help in Close Iowa Race

Scholten said the House Democrats’ campaign arm “begged” him to run against Steve King in 2020. When King lost his primary, the DCCC lost interest.

USPS Workers Concerned New Policies Will Pave the Way to Privatization

Rachel M. Cohen

USPS Workers Concerned New Policies Will Pave the Way to Privatization

Rachel M. Cohen

USPS Workers Concerned New Policies Will Pave the Way to Privatization

Rachel M. Cohen

A barrage of new changes have come down, including delayed mail sortation. Workers say they threaten USPS’s core mission.

The headquarters of Purdue Pharma seen through a window from a building opposite

The New Fight to Hold Purdue Pharma and the Sacklers Accountable for the Opioid Crisis

Natasha Lennard

The headquarters of Purdue Pharma seen through a window from a building opposite

Voices

The New Fight to Hold Purdue Pharma and the Sacklers Accountable for the Opioid Crisis

Natasha Lennard

The headquarters of Purdue Pharma seen through a window from a building opposite

Voices

The New Fight to Hold Purdue Pharma and the Sacklers Accountable for the Opioid Crisis

Natasha Lennard

Victim advocates fear that bankruptcy will shield the drugmaker from justice, but they’re not giving up.